Using AI to speed up drug development and model building
DelineateQSP: Accelerating Quantitative Systems Pharmacology Model Building and Repurposing
This study is working on a new tool that uses advanced computer technology to help researchers build better models for understanding how drugs work in the body, which could make it faster and easier to develop new treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Delineate INC NIH-funded |
| Lab location | 1 site (Medford, United States) |
| Project ID | NIH-11069100 on NIH RePORTER |
What this research studies
This research focuses on creating a platform that utilizes Large Language Models (LLMs) to enhance the construction and repurposing of Quantitative Systems Pharmacology (QSP) models. By extracting data from scientific literature more efficiently, the project aims to streamline the drug development process and improve clinical trial outcomes. The approach includes validating the platform through the development of test models and tracking model accuracy. If successful, this innovative method could significantly reduce the time and resources needed to develop new treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with conditions that are currently being studied for new treatments or those involved in clinical trials.
Not a fit: Patients who are not involved in drug development or clinical trials may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective drug development, ultimately resulting in new life-saving therapies for patients.
How similar studies have performed: Other research has shown promise in using AI and machine learning to enhance drug development processes, indicating that this approach could be effective.
Where this research is happening
Medford, United States
- Delineate INC — Medford, United States (Active)
Researchers
- Principal investigator: Iqbal, Jawad — Delineate INC
- Study coordinator: Iqbal, Jawad
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.